Fuad El-Hibri - Insider Trading Tracker

Aptevo Therapeutics Inc.

US ˙ NasdaqCM

소개

이 페이지에서는 Fuad El-Hibri의 공개된 내부자의 매매 거래 내역을 종합적으로 분석합니다. 내부자들은 기업의 임원(내부 경영진), 이사 또는 주요 투자자입니다. 일반적으로 내부자가 중요한 비공개 정보를 기반으로 자신이 속한 기업을 거래하는 것은 불법으로 간주됩니다. 이것은 내부자가 자신의 기업 내에서 행하는 모든 거래가 불법이라는 것을 뜻은 아닙니다. 그러나 그들은 자신들의 모든 거래를 양식 4를 통해 SEC에 보고해야만 합니다. 이러한 제한에도 불구하고, 학계 연구에 따르면 내부자는, 일반적으로, 자신의 회사 주식에 대한 실적이 시장의 수익률을 능가하는 경향성을 보였습니다.

평균 거래 수익성

평균 거래 수익성은 내부자가 지난 3년 동안 매입한 모든 "공개 시장"(Open market)에서의 매입의 평균 수익률입니다. 이를 계산하기 위해 10b5-1 거래 계획의 일부로 표시된 모든 거래를 제외하고 내부자가 계획되지 않은 모든 오픈 마켓에서의 매입을 조사합니다. 그런 다음 3개월, 6개월, 12개월 동안 해당 거래의 평균 성과를 계산하여 각 거래에 대한 최종 성과 지표를 생성합니다. 마지막으로 내부자에 대한 성과 지표를 계산하기 위해 모든 성과 지표의 평균을 내립니다. 이 목록에는 지난 2년 동안 최소 3번 이상 거래한 내부자만 포함됩니다.

내부자의 매매 거래 수익성이 "해당 없음"인 경우, 내부자는 지난 3년 동안 공개 시장에서 매수한 적이 없거나, 거래가 너무 최근에 이루어져서 신뢰할 수 있는 성과 지표를 산출할 수 없는 경우에 해당합니다.

업데이트 주기: 일별

최고 수익율의 내부자 목록을 확인하세요.

가장 높은 순위의 내부자를 확인하세요

내부자 포지션이 보고된 기업

SEC 서류에 따르면 Fuad El-Hibri 기업이 다음 기업에 대한 보유 또는 거래를 보고했습니다:

증권	소유권	최근 보고된 보유 주식
US:EBS / Emergent BioSolutions Inc.	Director	206,434
US:APVO / Aptevo Therapeutics Inc.	Director	7,373

차트 해석 방법

아래 차트는 Fuad El-Hibri에 의한 각 "공개 시장"(Open market)에서 계획되지 않은 거래 이후 증권의 주가 실적을 보여줍니다. 계획되지 않은 거래는 10b5-1 거래 계획의 일환으로 이루어지지 않은 거래입니다. 주가 실적은 주가의 누적 백분율 변화로 표시됩니다. 예를 들어, 2019년 1월 1일 내부자의 매매 거래가 이루어졌을 경우, 차트는 현재까지 증권의 일별 백분율 변화를 보여줍니다. 이 기간 동안 주가가 10달러에서 15달러로 간다면, 주가의 누적 백분율 변화는 50%가 됩니다. 10달러에서 20달러로의 가격 변화는 100%가 되며, 10달러에서 5달러로의 가격 변화는 -50%가 됩니다.

궁극적으로 내부자의 매매 거래가 내부자의 정보를 이용하여 이익을 얻기 위해 거래 타이밍을 맞추고 있는지 확인하기 위해 내부자의 매매 거래가 주가의 초과 수익률(양 또는 음)과 얼마나 밀접한 상관 관계가 있는지 확인하고자 합니다. 내부자가 이러한 작업을 수행하고 있는 상황을 고려해 보겠습니다. 이러한 상황에서 우리는 (a) 매입 후 양의 수익률 또는 (b) 매각 후 음의 수익률을 기대할 수 있습니다. (a)의 경우, 매입 차트는 상향으로 기울어진 일련의 곡선을 보여주며, 각 매입 거래 후 양의 수익률을 나타냅니다. (b)의 경우, SALE 차트는 하향으로 기울어진 일련의 곡선을 보여주며, 각 판매 거래 후 음의 수익률을 나타냅니다.

그러나 이것만으로는 결론을 도출하기에 충분하지 않습니다. 예를 들어, 해당 기업의 주가가 수년에 걸쳐 비주기적 상승 추세에 있다면, Fintel은 매입 후 도표가 모두 상향 곡선으로 예상할 수 있습니다. 마찬가지로, 수년에 걸쳐 비주기적 하락은 거래 후에 하향 곡선으로 초래할 가능성이 높습니다. 이 도표들 중 어느 것도 내부자의 매매 거래 활동을 시사하지는 않습니다.

가장 강력한 지표는 주가가 극단적으로 순환하는 상황일 것이고, PURCHASE 차트에는 긍정적인 시그널이, SALE 차트에는 부정적인 플롯이 존재했습니다. 이는 자신들의 금전적 이익을 위한 거래 타이밍을 재던 내부자에 의한 상황일 가능성이 높습니다.

내부자 매입 APVO / Aptevo Therapeutics Inc.: 단기 이익 분석

이 섹션에서는 APVO / Aptevo Therapeutics Inc.에 대한 "공개 시장"(Open market)에서 계획되지 않은 내부자의 매입이 발생한 모든 상품의 수익성을 분석합니다. 이 분석은 내부자가 지속적으로 비정상적인 수익을 창출하는지 이해하는 데 도움이 되며, 이를 따를 가치가 있습니다. 이 분석은 각 거래 후 1년 동안 수행되며, 결과는 이론 값입니다.

아래 표는 사전 거래 계획(Automated trading plan)에 포함되지 않은 가장 최근의 공개 시장 매입을 보여줍니다.

거래일	티커	내부자	보고된 지분	보고된 가격	조정된 지분	조정된 가격	가격 기준	최고까지 일수	최고 가격	최고 이익 ($)	최고 수익률 (%)
2019-07-29	APVO	El-Hibri Fuad	55,015	0.8336	2,068	22.1738	45,861	10	13.7564	-17,412	-37.97
2019-07-23	APVO	El-Hibri Fuad	10,000	0.8996	376	23.9294	8,996
2019-07-22	APVO	El-Hibri Fuad	30,000	0.8867	1,128	23.5862	26,601
2019-07-19	APVO	El-Hibri Fuad	26,460	0.8972	995	23.8655	23,740
2019-07-18	APVO	El-Hibri Fuad	14,404	0.8745	542	23.2617	12,596
2019-07-17	APVO	El-Hibri Fuad	19,136	0.8729	719	23.2191	16,704
2019-07-16	APVO	El-Hibri Fuad	11,375	0.8494	428	22.5940	9,662
2019-07-11	APVO	El-Hibri Fuad	14,691	0.8477	552	22.5488	12,454
2019-07-10	APVO	El-Hibri Fuad	18,919	0.8488	711	22.5781	16,058

조정 가격은 분할 조정된 가격입니다. 조정된 주식은 조정된 지분입니다.

APVO / Aptevo Therapeutics Inc. Insider Trades

내부자 매매 APVO / Aptevo Therapeutics Inc.: 단기 손실 분석

이 섹션에서는 APVO / Aptevo Therapeutics Inc.에서 이루어진 계획되지 않은 모든 공개 시장에서의 내부자 매도의 단기 손실 회피를 분석합니다. 일관된 손실 회피 패턴은 향후 매각 거래에서 가격 하락이 발생할 수도 있다는 것을 예측할 수 있습니다. 이 분석은 각 거래 후 1년을 대상으로 한 것이며, 결과는 이론 값입니다.

아래 표는 자동 거래 계획에 포함되지 않은 가장 최근의 "공개 시장"(Open market) 매매를 보여줍니다.

거래일	티커	내부자	보고된 지분	보고된 가격	조정된 지분	조정된 가격	가격 기준	최저까지 일수	최저에서 가격	회피된 최대 손실($)	회피된 최대 손실율(%)
이 내부자와 유가 증권의 조합과 관련하여 계획되지 않은 공개된 "공개 시장"(Open market) 거래는 없습니다.

조정 가격은 분할 조정된 가격입니다. 조정된 주식은 조정된 지분입니다.

내부자 매입 EBS / Emergent BioSolutions Inc.: 단기 이익 분석

아래 표는 사전 거래 계획(Automated trading plan)에 포함되지 않은 가장 최근의 공개 시장 매입을 보여줍니다.

거래일	티커	내부자	보고된 지분	보고된 가격	조정된 지분	조정된 가격	가격 기준	최고까지 일수	최고 가격	최고 이익 ($)	최고 수익률 (%)
이 내부자와 유가 증권의 조합과 관련하여 계획되지 않은 공개된 "공개 시장"(Open market) 거래는 없습니다.

조정 가격은 분할 조정된 가격입니다. 조정된 주식은 조정된 지분입니다.

EBS / Emergent BioSolutions Inc. Insider Trades

내부자 매매 EBS / Emergent BioSolutions Inc.: 단기 손실 분석

아래 표는 자동 거래 계획에 포함되지 않은 가장 최근의 "공개 시장"(Open market) 매매를 보여줍니다.

거래일	티커	내부자	보고된 지분	보고된 가격	조정된 지분	조정된 가격	가격 기준	최저까지 일수	최저에서 가격	회피된 최대 손실($)	회피된 최대 손실율(%)
2020-02-06	EBS	El-Hibri Fuad	11,684	61.9000	11,684	61.9000	723,240	43	49.34	-146,750	-20.29
2015-11-19	EBS	El-Hibri Fuad	17,871	37.5000	17,871	37.5000	670,162
2015-11-13	EBS	El-Hibri Fuad	13,013	36.5000	13,013	36.5000	474,974
2015-11-09	EBS	El-Hibri Fuad	13,225	35.5000	13,225	35.5000	469,488
2015-11-06	EBS	El-Hibri Fuad	13,450	34.5000	13,450	34.5000	464,025
2015-11-03	EBS	El-Hibri Fuad	13,689	33.5000	13,689	33.5000	458,582
2013-04-18	EBS	El-Hibri Fuad	62,851	15.0452	62,851	15.0452	945,606
2013-04-17	EBS	El-Hibri Fuad	52,021	15.0196	52,021	15.0196	781,335
2012-12-04	EBS	El-Hibri Fuad	43,064	15.0831	43,064	15.0831	649,539
2012-12-03	EBS	El-Hibri Fuad	22,875	15.0197	22,875	15.0197	343,576
2012-11-30	EBS	El-Hibri Fuad	34,061	15.2146	34,061	15.2146	518,224
2008-08-28	EBS	El-Hibri Fuad	8,000	14.0000	8,000	14.0000	112,000
2008-08-28	EBS	El-Hibri Fuad	200	14.0050	200	14.0050	2,801
2008-08-28	EBS	El-Hibri Fuad	300	14.0100	300	14.0100	4,203
2008-08-28	EBS	El-Hibri Fuad	500	14.0200	500	14.0200	7,010
2008-08-28	EBS	El-Hibri Fuad	800	14.0300	800	14.0300	11,224
2008-08-28	EBS	El-Hibri Fuad	100	14.0400	100	14.0400	1,404
2008-08-28	EBS	El-Hibri Fuad	200	14.0500	200	14.0500	2,810
2008-08-28	EBS	El-Hibri Fuad	3,700	14.0600	3,700	14.0600	52,022
2008-08-28	EBS	El-Hibri Fuad	1,700	14.0700	1,700	14.0700	23,919
2008-08-28	EBS	El-Hibri Fuad	400	14.0800	400	14.0800	5,632
2008-08-28	EBS	El-Hibri Fuad	100	14.0850	100	14.0850	1,408
2008-08-28	EBS	El-Hibri Fuad	350	14.0900	350	14.0900	4,932
2008-08-28	EBS	El-Hibri Fuad	600	14.1000	600	14.1000	8,460
2008-08-28	EBS	El-Hibri Fuad	300	14.1100	300	14.1100	4,233
2008-08-28	EBS	El-Hibri Fuad	600	14.1200	600	14.1200	8,472
2008-08-28	EBS	El-Hibri Fuad	700	14.1300	700	14.1300	9,891
2008-08-28	EBS	El-Hibri Fuad	200	14.1400	200	14.1400	2,828
2008-08-28	EBS	El-Hibri Fuad	100	14.1500	100	14.1500	1,415
2008-08-28	EBS	El-Hibri Fuad	50	14.1600	50	14.1600	708
2008-08-28	EBS	El-Hibri Fuad	800	14.1700	800	14.1700	11,336
2008-08-28	EBS	El-Hibri Fuad	400	14.1800	400	14.1800	5,672
2008-08-28	EBS	El-Hibri Fuad	1,000	14.1900	1,000	14.1900	14,190
2008-08-28	EBS	El-Hibri Fuad	500	14.2000	500	14.2000	7,100
2008-08-28	EBS	El-Hibri Fuad	200	14.2100	200	14.2100	2,842
2008-08-28	EBS	El-Hibri Fuad	650	14.2200	650	14.2200	9,243
2008-08-28	EBS	El-Hibri Fuad	100	14.2300	100	14.2300	1,423

조정 가격은 분할 조정된 가격입니다. 조정된 주식은 조정된 지분입니다.

내부자의 매매 거래 내역

아래 표는 증권거래위원회(SEC)에 공시된 Fuad El-Hibri의 내부자의 전체 거래 목록입니다.

보고일	거래일	보고	티커	증권	코드	10b5-1	지분	잔여 지분	변동률 (%)	지분 가치	거래 가치	잔여 가치
2021-12-07	2021-12-03	4	EBS	Emergent BioSolutions Inc. Common Stock	J - Other		206,434	206,434
2021-12-07	2021-12-03	4	EBS	Emergent BioSolutions Inc. Common Stock	J - Other		274,930	274,930
2021-12-07	2021-12-03	4	EBS	Emergent BioSolutions Inc. Common Stock	J - Other		3,018,644	3,018,644
2021-12-07	2021-12-03	4	APVO	Aptevo Therapeutics Inc. Common Stock	J - Other		7,373	7,373
2021-12-07	2021-12-03	4	APVO	Aptevo Therapeutics Inc. Common Stock	J - Other		9,819	9,819
2021-12-07	2021-12-03	4	APVO	Aptevo Therapeutics Inc. Common Stock	J - Other		107,807	107,807
2021-06-02	2021-06-01	4	APVO	Aptevo Therapeutics Inc. Restricted Stock Unit	A - Award		893	893
2021-06-02	2021-06-01	4	APVO	Aptevo Therapeutics Inc. Stock Option (right to buy)	A - Award		2,678	2,678
2021-02-26	2021-02-24	4	EBS	Emergent BioSolutions Inc. Restricted Stock Unit	A - Award		13,906	13,906
2021-02-26	2021-02-24	4	EBS	Emergent BioSolutions Inc. Employee Stock Options (Right to Buy)	A - Award		27,808	27,808
2021-02-17	2020-07-02	4	APVO	Aptevo Therapeutics Inc. Stock Option (right to buy)	A - Award		3,571	3,571
2020-11-12	2020-11-10	4	EBS	Emergent BioSolutions Inc. Stock Options (Right to Buy)	M - Exercise	X	-19,391	0	-100.00
2020-11-12	2020-11-10	4	EBS	Emergent BioSolutions Inc. Common Stock	S - Sale	X	-19,391	1,123,988	-1.70	88.21	-1,710,480	99,146,981
2020-11-12	2020-11-10	4	EBS	Emergent BioSolutions Inc. Common Stock	M - Exercise	X	19,391	1,143,379	1.73	26.45	512,892	30,242,375
2020-11-12	2020-11-09	4	EBS	Emergent BioSolutions Inc. Stock Options (Right to Buy)	M - Exercise	X	-20,000	19,391	-50.77
2020-11-12	2020-11-09	4	EBS	Emergent BioSolutions Inc. Common Stock	S - Sale	X	-20,000	1,123,988	-1.75	95.26	-1,905,200	107,071,097
2020-11-12	2020-11-09	4	EBS	Emergent BioSolutions Inc. Common Stock	M - Exercise	X	20,000	1,143,988	1.78	26.45	529,000	30,258,483
2020-11-04	2020-11-03	4	EBS	Emergent BioSolutions Inc. Stock Options (Right to Buy)	M - Exercise	X	-20,000	39,391	-33.68
2020-11-04	2020-11-03	4	EBS	Emergent BioSolutions Inc. Common Stock	S - Sale	X	-20,000	1,123,988	-1.75	90.74	-1,814,800	101,990,671
2020-11-04	2020-11-03	4	EBS	Emergent BioSolutions Inc. Common Stock	M - Exercise	X	20,000	1,143,988	1.78	26.45	529,000	30,258,483
2020-11-04	2020-11-02	4	EBS	Emergent BioSolutions Inc. Stock Options (Right to Buy)	M - Exercise	X	-20,000	59,391	-25.19
2020-11-04	2020-11-02	4	EBS	Emergent BioSolutions Inc. Common Stock	S - Sale	X	-20,000	1,123,988	-1.75	90.44	-1,808,800	101,653,475
2020-11-04	2020-11-02	4	EBS	Emergent BioSolutions Inc. Common Stock	M - Exercise	X	20,000	1,143,988	1.78	26.45	529,000	30,258,483
2020-09-25	2020-09-24	4	EBS	Emergent BioSolutions Inc. Common Stock	S - Sale	X	-12,535	1,123,988	-1.10	98.85	-1,239,085	111,106,214
2020-09-25	2020-09-23	4	EBS	Emergent BioSolutions Inc. Common Stock	S - Sale	X	-13,000	1,136,523	-1.13	100.58	-1,307,540	114,311,483
2020-09-18	2020-09-17	4	EBS	Emergent BioSolutions Inc. Common Stock	S - Sale	X	-20,000	1,149,523	-1.71	100.68	-2,013,600	115,733,976
2020-09-18	2020-09-16	4	EBS	Emergent BioSolutions Inc. Common Stock	S - Sale	X	-20,000	1,169,523	-1.68	102.48	-2,049,600	119,852,717
2020-09-11	2020-09-10	4	EBS	Emergent BioSolutions Inc. Common Stock	S - Sale	X	-20,000	1,189,523	-1.65	102.66	-2,053,200	122,116,431
2020-09-11	2020-09-09	4	EBS	Emergent BioSolutions Inc. Common Stock	S - Sale	X	-20,000	1,209,523	-1.63	102.80	-2,056,000	124,338,964
2020-07-29	2020-07-27	4	APVO	Aptevo Therapeutics Inc. Stock Option (right to buy)	A - Award		170	170
2020-07-29	2020-07-27	4	APVO	Aptevo Therapeutics Inc. Stock Option (right to buy)	A - Award		1,322	1,322
2020-07-29	2020-07-27	4	APVO	Aptevo Therapeutics Inc. Stock Option (right to buy)	D - Sale to Issuer		-1,785	0	-100.00
2020-07-29	2020-07-27	4	APVO	Aptevo Therapeutics Inc. Stock Option (right to buy)	D - Sale to Issuer		-892	0	-100.00
2020-07-29	2020-07-27	4	APVO	Aptevo Therapeutics Inc. Stock Option (right to buy)	D - Sale to Issuer		-1,339	0	-100.00
2020-05-01	2020-04-30	4	EBS	Emergent BioSolutions Inc. Common Stock	S - Sale	X	-20,000	1,229,523	-1.60	74.01	-1,480,200	90,996,997
2020-05-01	2020-04-29	4	EBS	Emergent BioSolutions Inc. Common Stock	S - Sale	X	-20,000	1,249,523	-1.58	74.24	-1,484,800	92,764,588
2020-04-24	2020-04-23	4	EBS	Emergent BioSolutions Inc. Common Stock	S - Sale	X	-20,000	1,269,523	-1.55	68.49	-1,369,800	86,949,630
2020-04-24	2020-04-22	4	EBS	Emergent BioSolutions Inc. Common Stock	S - Sale	X	-20,000	1,289,523	-1.53	66.81	-1,336,200	86,153,032
2020-04-20	2020-04-16	4	EBS	Emergent BioSolutions Inc. Common Stock	S - Sale	X	-20,000	1,309,523	-1.50	62.47	-1,249,400	81,805,902
2020-04-15	2020-04-15	4	EBS	Emergent BioSolutions Inc. Common Stock	S - Sale	X	-12,537	1,329,523	-0.93	62.58	-784,565	83,201,549
2020-04-15	2020-04-14	4	EBS	Emergent BioSolutions Inc. Common Stock	S - Sale	X	-6,261	1,342,060	-0.46	62.99	-394,380	84,536,359
2020-04-15	2020-04-13	4	EBS	Emergent BioSolutions Inc. Common Stock	S - Sale	X	-17,071	1,348,321	-1.25	62.25	-1,062,670	83,932,982
2020-04-10	2020-04-09	4	EBS	Emergent BioSolutions Inc. Common Stock	S - Sale	X	-23,716	1,365,392	-1.71	61.83	-1,466,360	84,422,187
2020-04-10	2020-04-08	4	EBS	Emergent BioSolutions Inc. Common Stock	S - Sale	X	-24,362	1,389,108	-1.72	61.34	-1,494,365	85,207,885
2020-04-10	2020-04-08	4	EBS	Emergent BioSolutions Inc. Common Stock	S - Sale	X	-13,000	1,413,470	-0.91	60.75	-789,750	85,868,302
2020-04-08	2020-04-07	4	EBS	Emergent BioSolutions Inc. Common Stock	S - Sale	X	-14,336	1,426,470	-0.99	60.76	-871,055	86,672,317
2020-04-08	2020-04-06	4	EBS	Emergent BioSolutions Inc. Common Stock	S - Sale	X	-28,240	1,440,806	-1.92	60.50	-1,708,520	87,168,763
2020-02-28	2020-02-27	4	EBS	Emergent BioSolutions Inc. Restricted Stock Unit	M - Exercise		-9,794	37,980	-20.50
2020-02-28	2020-02-27	4	EBS	Emergent BioSolutions Inc. Common Stock	S - Sale	X	-9,837	1,469,046	-0.67	56.97	-560,414	83,691,551
2020-02-28	2020-02-27	4	EBS	Emergent BioSolutions Inc. Common Stock	F - Taxes		-3,854	1,478,883	-0.26	58.42	-225,151	86,396,345
2020-02-28	2020-02-27	4	EBS	Emergent BioSolutions Inc. Common Stock	M - Exercise		9,794	1,482,737	0.66
2020-02-28	2020-02-26	4	EBS	Emergent BioSolutions Inc. Restricted Stock Unit	M - Exercise		-6,429	47,774	-11.86
2020-02-28	2020-02-26	4	EBS	Emergent BioSolutions Inc. Common Stock	S - Sale	X	-13,619	1,472,943	-0.92	58.70	-799,435	86,461,754
2020-02-28	2020-02-26	4	EBS	Emergent BioSolutions Inc. Common Stock	F - Taxes		-2,530	1,486,562	-0.17	59.91	-151,572	89,059,929
2020-02-28	2020-02-26	4	EBS	Emergent BioSolutions Inc. Common Stock	M - Exercise		6,429	1,489,092	0.43
2020-02-28	2020-02-26	4	EBS	Emergent BioSolutions Inc. Common Stock	F - Taxes		-2,365	1,482,663	-0.16	59.91	-141,687	88,826,340
2020-02-27	2020-02-25	4	EBS	Emergent BioSolutions Inc. Restricted Stock Unit	M - Exercise		-6,010	54,203	-9.98
2020-02-27	2020-02-25	4	EBS	Emergent BioSolutions Inc. Restricted Stock Unit	A - Award		19,532	60,213	48.01
2020-02-27	2020-02-25	4	EBS	Emergent BioSolutions Inc. Employee Stock Options (Right to Buy)	A - Award		39,061	39,061
2020-02-27	2020-02-25	4	EBS	Emergent BioSolutions Inc. Common Stock	M - Exercise		6,010	1,485,028	0.41
2020-02-24	2020-02-21	4	EBS	Emergent BioSolutions Inc. Employee Stock Options (Right to Buy)	M - Exercise	X	-18,567	0	-100.00
2020-02-24	2020-02-21	4	EBS	Emergent BioSolutions Inc. Common Stock	S - Sale	X	-18,567	1,479,018	-1.24	64.90	-1,204,998	95,988,268
2020-02-24	2020-02-21	4	EBS	Emergent BioSolutions Inc. Common Stock	M - Exercise	X	18,567	1,497,585	1.26	25.62	475,687	38,368,128
2020-02-24	2020-02-20	4	EBS	Emergent BioSolutions Inc. Employee Stock Options (Right to Buy)	M - Exercise	X	-4,751	18,567	-20.37
2020-02-24	2020-02-20	4	EBS	Emergent BioSolutions Inc. Common Stock	S - Sale	X	-4,751	1,479,018	-0.32	64.90	-308,340	95,988,268
2020-02-24	2020-02-20	4	EBS	Emergent BioSolutions Inc. Common Stock	M - Exercise	X	4,751	1,483,769	0.32	25.62	121,721	38,014,162
2020-02-19	2020-02-18	4	EBS	Emergent BioSolutions Inc. Employee Stock Options (Right to Buy)	M - Exercise	X	-15,614	23,318	-40.11
2020-02-19	2020-02-18	4	EBS	Emergent BioSolutions Inc. Common Stock	S - Sale	X	-15,614	1,479,018	-1.04	63.90	-997,735	94,509,250
2020-02-19	2020-02-18	4	EBS	Emergent BioSolutions Inc. Common Stock	M - Exercise	X	15,614	1,494,632	1.06	25.62	400,031	38,292,472
2020-02-19	2020-02-14	4	EBS	Emergent BioSolutions Inc. Employee Stock Options (Right to Buy)	M - Exercise	X	-4,386	38,932	-10.13
2020-02-19	2020-02-14	4	EBS	Emergent BioSolutions Inc. Common Stock	S - Sale	X	-4,386	1,479,018	-0.30	63.90	-280,265	94,509,250
2020-02-19	2020-02-14	4	EBS	Emergent BioSolutions Inc. Common Stock	M - Exercise	X	4,386	1,483,404	0.30	25.62	112,369	38,004,810
2020-02-13	2020-02-12	4	EBS	Emergent BioSolutions Inc. Employee Stock Options (Right to Buy)	M - Exercise	X	-13,720	43,318	-24.05
2020-02-13	2020-02-12	4	EBS	Emergent BioSolutions Inc. Common Stock	S - Sale	X	-13,720	1,479,018	-0.92	62.90	-862,988	93,030,232
2020-02-13	2020-02-12	4	EBS	Emergent BioSolutions Inc. Common Stock	M - Exercise	X	13,720	1,492,738	0.93	25.62	351,506	38,243,948
2020-02-13	2020-02-11	4	EBS	Emergent BioSolutions Inc. Employee Stock Options (Right to Buy)	M - Exercise	X	-6,280	57,038	-9.92
2020-02-13	2020-02-11	4	EBS	Emergent BioSolutions Inc. Common Stock	S - Sale	X	-6,280	1,479,018	-0.42	62.90	-395,012	93,030,232
2020-02-13	2020-02-11	4	EBS	Emergent BioSolutions Inc. Common Stock	M - Exercise	X	6,280	1,485,298	0.42	25.62	160,894	38,053,335
2020-02-13	2020-02-06	4/A	EBS	Emergent BioSolutions Inc. Employee Stock Options (Right to Buy)	M - Exercise	X	-11,684	63,318	-15.58
2020-02-13	2020-02-06	4/A	EBS	Emergent BioSolutions Inc. Common Stock	M - Exercise	X	11,684	1,479,018	0.80	25.62	299,344	37,892,441
2020-02-13	2020-02-05	4/A	EBS	Emergent BioSolutions Inc. Employee Stock Options (Right to Buy)	M - Exercise	X	-8,316	75,002	-9.98
2020-02-13	2020-02-05	4/A	EBS	Emergent BioSolutions Inc. Employee Stock Options (Right to Buy)	M - Exercise	X	-20,000	83,318	-19.36
2020-02-13	2020-02-05	4/A	EBS	Emergent BioSolutions Inc. Employee Stock Options (Right to Buy)	M - Exercise	X	-20,000	103,318	-16.22
2020-02-13	2020-02-05	4/A	EBS	Emergent BioSolutions Inc. Common Stock	M - Exercise	X	8,316	1,479,018	0.57	25.62	213,056	37,892,441
2020-02-13	2020-02-05	4/A	EBS	Emergent BioSolutions Inc. Common Stock	M - Exercise	X	20,000	1,519,018	1.33	25.62	512,400	38,917,241
2020-02-13	2020-02-05	4/A	EBS	Emergent BioSolutions Inc. Common Stock	M - Exercise	X	20,000	1,499,018	1.35	25.62	512,400	38,404,841
2020-02-07	2020-02-06	4	EBS	Emergent BioSolutions Inc. Common Stock	S - Sale		-11,684	1,419,018	-0.82	61.90	-723,240	87,837,214
2020-02-07	2020-02-05	4	EBS	Emergent BioSolutions Inc. Common Stock	S - Sale	X	-48,316	1,430,702	-3.27	60.66	-2,930,849	86,786,383
2019-08-13	2019-08-12	4	APVO	Aptevo Therapeutics Inc. Common Stock	P - Purchase	X	100,000	1,124,536	9.76	0.76	75,520	849,250
2019-07-30	2019-07-29	4	APVO	Aptevo Therapeutics Inc. Common Stock	P - Purchase		55,015	1,024,536	5.67	0.83	45,861	854,053
2019-07-24	2019-07-23	4	APVO	Aptevo Therapeutics Inc. Common Stock	P - Purchase		10,000	969,521	1.04	0.90	8,996	872,181
2019-07-23	2019-07-22	4	APVO	Aptevo Therapeutics Inc. Common Stock	P - Purchase		30,000	959,521	3.23	0.89	26,601	850,807
2019-07-19	2019-07-19	4	APVO	Aptevo Therapeutics Inc. Common Stock	P - Purchase		26,460	929,521	2.93	0.90	23,740	833,966
2019-07-18	2019-07-17	4	APVO	Aptevo Therapeutics Inc. Common Stock	P - Purchase		19,136	888,657	2.20	0.87	16,704	775,709
2019-07-18	2019-07-18	4	APVO	Aptevo Therapeutics Inc. Common Stock	P - Purchase		14,404	903,061	1.62	0.87	12,596	789,727
2019-07-16	2019-07-16	4	APVO	Aptevo Therapeutics Inc. Common Stock	P - Purchase		11,375	869,521	1.33	0.85	9,662	738,571
2019-07-12	2019-07-11	4	APVO	Aptevo Therapeutics Inc. Common Stock	P - Purchase		14,691	858,146	1.74	0.85	12,454	727,450
2019-07-11	2019-07-10	4	APVO	Aptevo Therapeutics Inc. Common Stock	P - Purchase		18,919	843,455	2.29	0.85	16,058	715,925
2019-06-04	2019-06-01	4	APVO	Aptevo Therapeutics Inc. Option (right to buy)	A - Award		25,000	25,000
2019-02-28	2019-02-28	4	EBS	Emergent BioSolutions Inc. Restricted Stock Units	M - Exercise		-9,722	40,681	-19.29
2019-02-28	2019-02-28	4	EBS	Emergent BioSolutions Inc. Common Stock	F - Taxes		-3,826	1,479,018	-0.26	58.71	-224,624	86,833,147
2019-02-28	2019-02-28	4	EBS	Emergent BioSolutions Inc. Common Stock	M - Exercise		9,722	1,482,844	0.66
2019-02-28	2019-02-28	4	EBS	Emergent BioSolutions Inc. Common Stock	S - Sale	X	-6,987	1,473,122	-0.47	58.47	-408,530	86,133,443
2019-02-28	2019-02-27	4	EBS	Emergent BioSolutions Inc. Restricted Stock Units	M - Exercise		-9,794	50,403	-16.27
2019-02-28	2019-02-27	4	EBS	Emergent BioSolutions Inc. Common Stock	F - Taxes		-2,486	1,480,109	-0.17	57.98	-144,138	85,816,720
2019-02-28	2019-02-27	4	EBS	Emergent BioSolutions Inc. Common Stock	M - Exercise		9,794	1,482,595	0.66
2019-02-28	2019-02-27	4	EBS	Emergent BioSolutions Inc. Common Stock	S - Sale	X	-10,369	1,472,801	-0.70	58.24	-603,891	85,775,930
2019-02-28	2019-02-26	4	EBS	Emergent BioSolutions Inc. Stock Options (Right to Buy)	A - Award		36,053	36,053
2019-02-28	2019-02-26	4	EBS	Emergent BioSolutions Inc. Restricted Stock Units	A - Award		18,029	60,197	42.76
2019-02-28	2019-02-26	4	EBS	Emergent BioSolutions Inc. Restricted Stock Units	M - Exercise		-6,430	42,168	-13.23
2019-02-28	2019-02-26	4	EBS	Emergent BioSolutions Inc. Common Stock	F - Taxes		-1,566	1,483,170	-0.11	61.01	-95,542	90,488,202
2019-02-28	2019-02-26	4	EBS	Emergent BioSolutions Inc. Common Stock	M - Exercise		6,430	1,484,736	0.43
2019-02-28	2019-02-26	4	EBS	Emergent BioSolutions Inc. Common Stock	S - Sale	X	-10,369	1,478,306	-0.70	59.65	-618,511	88,180,953
2019-02-20	2018-11-27	4/A	EBS	Emergent BioSolutions Inc. Employee Stock Options (Right to Buy)	M - Exercise	X	-20,832	0	-100.00
2019-02-20	2018-11-27	4/A	EBS	Emergent BioSolutions Inc. Common Stock	S - Sale	X	-20,832	1,488,675	-1.38	69.59	-1,449,699	103,596,893
2019-02-20	2018-11-27	4/A	EBS	Emergent BioSolutions Inc. Common Stock	M - Exercise	X	20,832	1,509,507	1.40	13.38	278,732	20,197,204
2019-02-20	2018-11-26	4/A	EBS	Emergent BioSolutions Inc. Employee Stock Options (Right to Buy)	M - Exercise	X	-25,000	20,832	-54.55
2019-02-20	2018-11-26	4/A	EBS	Emergent BioSolutions Inc. Common Stock	M - Exercise	X	25,000	1,513,675	1.68	13.38	334,500	20,252,972
2019-02-20	2018-11-20	4/A	EBS	Emergent BioSolutions Inc. Employee Stock Options (Right to Buy)	M - Exercise	X	-15,173	0	-100.00
2019-02-20	2018-11-20	4/A	EBS	Emergent BioSolutions Inc. Common Stock	M - Exercise	X	15,173	1,503,848	1.02	14.44	219,098	21,715,565
2019-02-20	2018-11-19	4/A	EBS	Emergent BioSolutions Inc. Employee Stock Options (Right to Buy)	M - Exercise	X	-20,000	15,173	-56.86
2019-02-20	2018-11-19	4/A	EBS	Emergent BioSolutions Inc. Common Stock	M - Exercise	X	20,000	1,508,675	1.34	14.44	288,800	21,785,267
2018-11-28	2018-11-27	4	EBS	Emergent BioSolutions Inc. Common Stock	S - Sale	X	-20,832	1,407,670	-1.46	69.59	-1,449,699	97,959,755
2018-11-28	2018-11-26	4	EBS	Emergent BioSolutions Inc. Common Stock	S - Sale	X	-25,000	1,428,502	-1.72	69.96	-1,749,000	99,938,000
2018-11-21	2018-11-20	4	EBS	Emergent BioSolutions Inc. Common Stock	S - Sale	X	-15,173	1,453,502	-1.03	70.03	-1,062,565	101,788,745
2018-11-21	2018-11-19	4	EBS	Emergent BioSolutions Inc. Common Stock	S - Sale	X	-20,000	1,468,675	-1.34	69.54	-1,390,800	102,131,660
2018-08-15	2018-08-14	4	EBS	Emergent BioSolutions Inc. Common Stock	S - Sale	X	-16,318	1,488,675	-1.08	56.57	-923,109	84,214,345
2018-08-15	2018-08-13	4	EBS	Emergent BioSolutions Inc. Common Stock	S - Sale	X	-20,000	1,504,993	-1.31	55.50	-1,110,000	83,527,112
2018-07-16	2018-07-12	4	EBS	Emergent BioSolutions Inc. Common Stock	S - Sale	X	-2,600	1,524,993	-0.17	54.52	-141,752	83,142,618
2018-07-16	2018-07-12	4	EBS	Emergent BioSolutions Inc. Common Stock	S - Sale	X	-12,400	1,527,593	-0.81	54.50	-675,800	83,253,818
2018-07-11	2018-07-09	4	EBS	Emergent BioSolutions Inc. Common Stock	S - Sale	X	-15,000	1,539,993	-0.96	53.61	-804,150	82,559,025
2018-06-04	2018-06-01	4	APVO	Aptevo Therapeutics Inc. Stock Option (right to buy)	A - Award		25,000	25,000
2018-03-13	2018-03-09	4	EBS	Emergent BioSolutions Inc. Restrictive Stock Units	M - Exercise		-13,237	48,598	-21.41
2018-03-13	2018-03-09	4	EBS	Emergent BioSolutions Inc. Common Stock	F - Taxes		-3,224	1,554,993	-0.21	51.84	-167,132	80,610,837
2018-03-13	2018-03-09	4	EBS	Emergent BioSolutions Inc. Common Stock	M - Exercise		13,237	1,558,217	0.86
2018-03-01	2018-02-28	4	EBS	Emergent BioSolutions Inc. Restrictive Stock Units	M - Exercise		-9,723	61,835	-13.59
2018-03-01	2018-02-28	4	EBS	Emergent BioSolutions Inc. Common Stock	F - Taxes		-2,368	1,544,980	-0.15	49.97	-118,329	77,202,651
2018-03-01	2018-02-28	4	EBS	Emergent BioSolutions Inc. Common Stock	M - Exercise		9,723	1,547,348	0.63
2018-03-01	2018-02-27	4	EBS	Emergent BioSolutions Inc. Restrictive Stock Units	M - Exercise		-9,794	71,558	-12.04
2018-03-01	2018-02-27	4	EBS	Emergent BioSolutions Inc. Employee Stock Options (Right to Buy)	A - Award		38,577	38,577
2018-03-01	2018-02-27	4	EBS	Emergent BioSolutions Inc. Restrictive Stock Units	A - Award		19,288	81,352	31.08
2018-03-01	2018-02-27	4	EBS	Emergent BioSolutions Inc. Common Stock	F - Taxes		-2,385	1,537,625	-0.15	49.64	-118,391	76,327,705
2018-03-01	2018-02-27	4	EBS	Emergent BioSolutions Inc. Common Stock	M - Exercise		9,794	1,540,010	0.64
2017-11-30	2017-11-29	4	EBS	Emergent BioSolutions Inc. Employee Stock Options (Right to Buy)	M - Exercise		-27,983	0	-100.00
2017-11-30	2017-11-29	4	EBS	Emergent BioSolutions Inc. Common Stock	S - Sale	X	-27,983	1,530,216	-1.80	42.08	-1,177,525	64,391,489
2017-11-30	2017-11-29	4	EBS	Emergent BioSolutions Inc. Common Stock	M - Exercise	X	27,983	1,558,199	1.83	22.03	616,465	34,327,124
2017-11-30	2017-11-28	4	EBS	Emergent BioSolutions Inc. Employee Stock Options (Right to Buy)	M - Exercise		-20,000	27,983	-41.68
2017-11-30	2017-11-28	4	EBS	Emergent BioSolutions Inc. Common Stock	S - Sale	X	-20,000	1,530,216	-1.29	41.59	-831,800	63,641,683
2017-11-30	2017-11-28	4	EBS	Emergent BioSolutions Inc. Common Stock	M - Exercise	X	20,000	1,550,216	1.31	22.03	440,600	34,151,258
2017-11-17	2017-11-14	4/A	EBS	Emergent BioSolutions Inc. Employee Stock Options (Right to Buy)	M - Exercise		-20,000	47,983	-29.42
2017-11-17	2017-11-14	4/A	EBS	Emergent BioSolutions Inc. Common Stock	S - Sale	X	-20,000	1,530,216	-1.29	40.05	-801,000	61,285,151
2017-11-17	2017-11-14	4/A	EBS	Emergent BioSolutions Inc. Common Stock	M - Exercise	X	20,000	1,550,216	1.31	22.03	440,600	34,151,258
2017-11-17	2017-11-13	4/A	EBS	Emergent BioSolutions Inc. Employee Stock Options (Right to Buy)	M - Exercise		-20,000	67,983	-22.73
2017-11-17	2017-11-13	4/A	EBS	Emergent BioSolutions Inc. Common Stock	S - Sale	X	-20,000	1,530,216	-1.29	40.69	-813,800	62,264,489
2017-11-17	2017-11-13	4/A	EBS	Emergent BioSolutions Inc. Common Stock	M - Exercise	X	20,000	1,550,216	1.31	22.03	440,600	34,151,258
2017-11-15	2017-11-14	4	EBS	Emergent BioSolutions Inc. Common Stock	S - Sale	X	-20,000	1,490,216	-1.32	40.05	-801,000	59,683,151
2017-11-15	2017-11-13	4	EBS	Emergent BioSolutions Inc. Common Stock	S - Sale	X	-20,000	1,510,216	-1.31	40.69	-813,800	61,450,689
2017-09-29	2017-09-29	4	EBS	Emergent BioSolutions Inc. Common Stock	S - Sale	X	-25,000	1,530,216	-1.61	40.50	-1,012,500	61,973,748
2017-09-29	2017-09-27	4	EBS	Emergent BioSolutions Inc. Common Stock	S - Sale	X	-25,000	1,555,216	-1.58	39.50	-987,500	61,431,032
2017-09-14	2017-09-14	4	EBS	Emergent BioSolutions Inc. Common Stock	S - Sale	X	-23,547	1,580,216	-1.47	38.50	-906,560	60,838,316
2017-09-14	2017-09-12	4	EBS	Emergent BioSolutions Inc. Common Stock	S - Sale	X	-1,453	1,603,763	-0.09	38.50	-55,940	61,744,876
2017-09-08	2017-09-07	4	EBS	Emergent BioSolutions Inc. Common Stock	S - Sale	X	-16,439	1,605,216	-1.01	37.50	-616,462	60,195,600
2017-09-06	2017-09-05	4	EBS	Emergent BioSolutions Inc. Common Stock	S - Sale	X	-3,100	1,621,655	-0.19	37.50	-116,250	60,812,062
2017-09-01	2017-08-31	4	EBS	Emergent BioSolutions Inc. Common Stock	S - Sale	X	-5,461	1,624,755	-0.33	37.50	-204,788	60,928,312
2017-07-28	2017-07-27	4	EBS	Emergent BioSolutions Inc. Common Stock	S - Sale	X	-25,000	1,630,216	-1.51	36.50	-912,500	59,502,884
2017-07-21	2017-07-20	4	EBS	Emergent BioSolutions Inc. Common Stock	S - Sale	X	-25,000	1,655,216	-1.49	35.50	-887,500	58,760,168
2017-06-01	2017-06-01	4	APVO	Aptevo Therapeutics Inc. Employee Stock Option (right to buy)	A - Award		12,500	12,500
2017-03-10	2017-03-10	4	EBS	Emergent BioSolutions Inc. Restrictive Stock Units	M - Exercise		-20,554	62,064	-24.88
2017-03-10	2017-03-10	4	EBS	Emergent BioSolutions Inc. Common Stock	F - Taxes		-6,089	1,680,216	-0.36	31.05	-189,063	52,170,707
2017-03-10	2017-03-10	4	EBS	Emergent BioSolutions Inc. Common Stock	M - Exercise		20,554	1,686,305	1.23
2017-03-10	2017-03-09	4	EBS	Emergent BioSolutions Inc. Restrictive Stock Units	M - Exercise		-13,236	82,618	-13.81
2017-03-10	2017-03-09	4	EBS	Emergent BioSolutions Inc. Common Stock	F - Taxes		-3,621	1,665,751	-0.22	30.98	-112,179	51,604,966
2017-03-10	2017-03-09	4	EBS	Emergent BioSolutions Inc. Common Stock	M - Exercise		13,236	1,669,372	0.80
2017-03-02	2017-02-28	4	EBS	Emergent BioSolutions Inc. Employee Stock Option (right to buy)	A - Award		58,747	58,747
2017-03-02	2017-02-28	4	EBS	Emergent BioSolutions Inc. Restrictive Stock Units	M - Exercise		-9,722	95,854	-9.21
2017-03-02	2017-02-28	4	EBS	Emergent BioSolutions Inc. Restrictive Stock Units	A - Award		29,382	105,576	38.56
2017-03-02	2017-02-28	4	EBS	Emergent BioSolutions Inc. Common Stock	F - Taxes		-2,659	1,656,136	-0.16	30.63	-81,445	50,727,446
2017-03-02	2017-02-28	4	EBS	Emergent BioSolutions Inc. Common Stock	M - Exercise		9,722	1,658,795	0.59
2016-08-05	2016-08-03	4	APVO	Aptevo Therapeutics Inc. Stock Option (right to buy)	A - Award		18,750	18,750
2016-05-27	2016-05-27	4	EBS	Emergent BioSolutions Inc. Common Stock	S - Sale	X	-9,835	1,649,073	-0.59	43.50	-427,822	71,734,676
2016-05-26	2016-05-26	4	EBS	Emergent BioSolutions Inc. Employee Stock Option (right to buy)	M - Exercise	X	-24,594	0	-100.00
2016-05-26	2016-05-26	4	EBS	Emergent BioSolutions Inc. Common Stock	S - Sale	X	-15,165	1,658,908	-0.91	43.50	-659,678	72,162,498
2016-05-26	2016-05-26	4	EBS	Emergent BioSolutions Inc. Common Stock	S - Sale	X	-24,594	1,674,073	-1.45	42.90	-1,055,083	71,817,732
2016-05-26	2016-05-26	4	EBS	Emergent BioSolutions Inc. Common Stock	M - Exercise	X	24,594	1,698,667	1.47	15.91	391,291	27,025,792
2016-05-25	2016-05-25	4	EBS	Emergent BioSolutions Inc. Employee Stock Option (right to buy)	M - Exercise	X	-20,000	24,594	-44.85
2016-05-25	2016-05-25	4	EBS	Emergent BioSolutions Inc. Common Stock	S - Sale	X	-20,000	1,674,073	-1.18	42.57	-851,400	71,265,288
2016-05-25	2016-05-25	4	EBS	Emergent BioSolutions Inc. Common Stock	M - Exercise	X	20,000	1,694,073	1.19	15.91	318,200	26,952,701
2016-05-25	2016-05-24	4	EBS	Emergent BioSolutions Inc. Employee Stock Option (right to buy)	M - Exercise	X	-20,000	44,594	-30.96
2016-05-25	2016-05-24	4	EBS	Emergent BioSolutions Inc. Common Stock	S - Sale	X	-20,000	1,674,073	-1.18	42.26	-845,200	70,746,325
2016-05-25	2016-05-24	4	EBS	Emergent BioSolutions Inc. Common Stock	M - Exercise	X	20,000	1,694,073	1.19	15.91	318,200	26,952,701
2016-05-25	2016-05-23	4	EBS	Emergent BioSolutions Inc. Employee Stock Option (right to buy)	M - Exercise	X	-20,000	64,594	-23.64
2016-05-25	2016-05-23	4	EBS	Emergent BioSolutions Inc. Common Stock	S - Sale	X	-25,000	1,674,073	-1.47	42.50	-1,062,500	71,148,102
2016-05-25	2016-05-23	4	EBS	Emergent BioSolutions Inc. Common Stock	S - Sale	X	-20,000	1,699,073	-1.16	42.76	-855,200	72,652,361
2016-05-25	2016-05-23	4	EBS	Emergent BioSolutions Inc. Common Stock	M - Exercise	X	20,000	1,719,073	1.18	15.91	318,200	27,350,451
2016-05-13	2016-05-12	4	EBS	Emergent BioSolutions Inc. Common Stock	S - Sale	X	-25,000	1,699,073	-1.45	38.71	-967,750	65,771,116
2016-04-25	2016-04-22	4	EBS	Emergent BioSolutions Inc. Common Stock	S - Sale	X	-4,209	1,724,073	-0.24	40.50	-170,464	69,824,956
2016-04-20	2016-04-18	4	EBS	Emergent BioSolutions Inc. Common Stock	S - Sale	X	-20,791	1,728,282	-1.19	40.50	-842,036	69,995,421
2016-04-08	2016-04-06	4	EBS	Emergent BioSolutions Inc. Common Stock	S - Sale	X	-25,000	1,749,073	-1.41	39.50	-987,500	69,088,384
2016-04-08	2016-04-06	4	EBS	Emergent BioSolutions Inc. Common Stock	S - Sale	X	-25,000	1,774,073	-1.39	38.50	-962,500	68,301,810
2016-03-15	2016-03-11	4	EBS	Emergent BioSolutions Inc. Restrictive Stock Units	M - Exercise		-6,967	69,196	-9.15
2016-03-15	2016-03-11	4	EBS	Emergent BioSolutions Inc. Common Stock	F - Taxes		-1,902	1,799,073	-0.11	34.22	-65,086	61,564,278
2016-03-15	2016-03-11	4	EBS	Emergent BioSolutions Inc. Common Stock	M - Exercise		6,967	1,800,975	0.39
2016-03-11	2016-03-10	4	EBS	Emergent BioSolutions Inc. Restrictive Stock Units	M - Exercise		-18,746	76,163	-19.75
2016-03-11	2016-03-10	4	EBS	Emergent BioSolutions Inc. Common Stock	F - Taxes		-5,128	1,794,008	-0.29	34.38	-176,301	61,677,995
2016-03-11	2016-03-10	4	EBS	Emergent BioSolutions Inc. Common Stock	M - Exercise		18,746	1,799,136	1.05
2016-03-11	2016-03-09	4	EBS	Emergent BioSolutions Inc. Restrictive Stock Units	M - Exercise		-12,073	94,909	-11.29
2016-03-11	2016-03-09	4	EBS	Emergent BioSolutions Inc. Common Stock	F - Taxes		-3,288	1,780,390	-0.18	34.60	-113,765	61,601,494
2016-03-11	2016-03-09	4	EBS	Emergent BioSolutions Inc. Common Stock	M - Exercise		12,073	1,783,678	0.68
2016-03-11	2016-03-01	4/A	EBS	Emergent BioSolutions Inc. Restrictive Stock Units	A - Award		26,303	106,982	32.60
2016-03-03	2016-03-01	4	EBS	Emergent BioSolutions Inc. Employee Stock Option (right to buy)	A - Award		53,192	53,192
2016-03-03	2016-03-01	4	EBS	Emergent BioSolutions Inc. Common Stock	A - Award		26,303	1,797,908	1.48
2015-11-19	2015-11-19	4	EBS	Emergent BioSolutions Inc. Employee Stock Option	M - Exercise		-27,900	0	-100.00
2015-11-19	2015-11-19	4	EBS	Emergent BioSolutions Inc. Common Stock	S - Sale		-17,871	1,852,284	-0.96	37.50	-670,162	69,460,650
2015-11-19	2015-11-19	4	EBS	Emergent BioSolutions Inc. Common Stock	M - Exercise	X	27,900	1,870,155	1.51	18.90	527,310	35,345,930
2015-11-16	2015-11-13	4	EBS	Emergent BioSolutions Inc. Employee Stock Option	M - Exercise		-20,000	27,900	-41.75
2015-11-16	2015-11-13	4	EBS	Emergent BioSolutions Inc. Common Stock	S - Sale		-13,013	1,842,255	-0.70	36.50	-474,974	67,242,308
2015-11-16	2015-11-13	4	EBS	Emergent BioSolutions Inc. Common Stock	M - Exercise	X	20,000	1,855,268	1.09	18.90	378,000	35,064,565
2015-11-10	2015-11-09	4	EBS	Emergent BioSolutions Inc. Employee Stock Option	M - Exercise		-20,000	47,900	-29.46
2015-11-10	2015-11-09	4	EBS	Emergent BioSolutions Inc. Common Stock	S - Sale		-13,225	1,835,268	-0.72	35.50	-469,488	65,152,014
2015-11-10	2015-11-09	4	EBS	Emergent BioSolutions Inc. Common Stock	M - Exercise	X	20,000	1,848,493	1.09	18.90	378,000	34,936,518
2015-11-06	2015-11-06	4	EBS	Emergent BioSolutions Inc. Employee Stock Option	M - Exercise		-20,000	67,900	-22.75
2015-11-06	2015-11-06	4	EBS	Emergent BioSolutions Inc. Common Stock	S - Sale		-13,450	1,828,493	-0.73	34.50	-464,025	63,083,008
2015-11-06	2015-11-06	4	EBS	Emergent BioSolutions Inc. Common Stock	M - Exercise	X	20,000	1,841,943	1.10	18.90	378,000	34,812,723
2015-11-04	2015-11-03	4	EBS	Emergent BioSolutions Inc. Employee Stock Option	M - Exercise		-20,000	87,900	-18.54
2015-11-04	2015-11-03	4	EBS	Emergent BioSolutions Inc. Common Stock	S - Sale		-13,689	1,821,943	-0.75	33.50	-458,582	61,035,090
2015-11-04	2015-11-03	4	EBS	Emergent BioSolutions Inc. Common Stock	M - Exercise	X	20,000	1,835,632	1.10	18.90	378,000	34,693,445
2015-08-10	2015-08-10	4	EBS	Emergent BioSolutions Inc. Common Stock	S - Sale	X	-30,000	1,815,632	-1.63	35.50	-1,065,000	64,454,936
2015-08-07	2015-08-06	4	EBS	Emergent BioSolutions Inc. Common Stock	S - Sale	X	-29,766	1,845,632	-1.59	34.50	-1,026,927	63,674,304
2015-07-22	2015-07-20	4	EBS	Emergent BioSolutions Inc. Common Stock	S - Sale	X	-234	1,875,398	-0.01	34.50	-8,073	64,701,231
2015-06-22	2015-06-22	4	EBS	Emergent BioSolutions Inc. Common Stock	S - Sale	X	-30,000	1,875,632	-1.57	33.00	-990,000	61,895,856
2015-06-22	2015-06-19	4	EBS	Emergent BioSolutions Inc. Common Stock	S - Sale	X	-30,000	1,905,632	-1.55	32.50	-975,000	61,933,040
2015-06-22	2015-06-18	4	EBS	Emergent BioSolutions Inc. Common Stock	S - Sale	X	-14,564	1,935,632	-0.75	32.00	-466,048	61,940,224
2015-06-15	2015-06-15	4	EBS	Emergent BioSolutions Inc. Common Stock	S - Sale	X	-368	1,950,196	-0.02	32.00	-11,776	62,406,272
2015-06-15	2015-06-12	4	EBS	Emergent BioSolutions Inc. Common Stock	S - Sale	X	-15,068	1,950,564	-0.77	32.03	-482,630	62,476,760
2015-06-15	2015-06-11	4	EBS	Emergent BioSolutions Inc. Common Stock	S - Sale	X	-30,000	1,965,632	-1.50	32.26	-967,923	63,419,347
2015-03-13	2015-03-12	4	EBS	Emergent BioSolutions Inc. Common Stock	F - Taxes		-1,463	1,995,632	-0.07	28.67	-41,944	57,214,769
2015-03-13	2015-03-11	4	EBS	Emergent BioSolutions Inc. Common Stock	F - Taxes		-1,906	1,997,095	-0.10	28.99	-55,255	57,895,784
2015-03-13	2015-03-10	4	EBS	Emergent BioSolutions Inc. Employee Stock Option (right to buy)	A - Award		72,413	72,413
2015-03-13	2015-03-10	4	EBS	Emergent BioSolutions Inc. Common Stock	F - Taxes		-5,128	1,999,001	-0.26	29.00	-148,712	57,971,029
2015-03-13	2015-03-10	4	EBS	Emergent BioSolutions Inc. Common Stock	A - Award		36,219	2,004,129	1.84
2015-01-21	2015-01-20	4	EBS	Emergent BioSolutions Inc. Employee Stock Option (right to buy)	M - Exercise	X	-33,333	0	-100.00
2015-01-21	2015-01-20	4	EBS	Emergent BioSolutions Inc. Common Stock	S - Sale	X	-7,303	1,967,910	-0.37	28.24	-206,232	55,572,401
2015-01-21	2015-01-20	4	EBS	Emergent BioSolutions Inc. Common Stock	S - Sale	X	-8,022	1,975,213	-0.40	27.16	-217,853	53,640,859
2015-01-21	2015-01-20	4	EBS	Emergent BioSolutions Inc. Common Stock	M - Exercise	X	33,333	1,983,235	1.71	7.00	233,331	13,882,645
2014-12-11	2014-12-11	4	EBS	Emergent BioSolutions Inc. Common Stock	S - Sale	X	-68,413	1,949,902	-3.39	26.00	-1,778,738	50,697,452
2014-12-11	2014-12-10	4	EBS	Emergent BioSolutions Inc. Common Stock	S - Sale	X	-416	2,018,315	-0.02	26.00	-10,816	52,476,190
2014-12-11	2014-12-09	4	EBS	Emergent BioSolutions Inc. Common Stock	S - Sale	X	-50,512	2,018,731	-2.44	26.00	-1,313,312	52,487,006
2014-12-01	2014-11-28	4	EBS	Emergent BioSolutions Inc. Common Stock	S - Sale	X	-13,597	0	-100.00	25.00	-339,925
2014-12-01	2014-11-28	4	EBS	Emergent BioSolutions Inc. Common Stock	S - Sale	X	-5,135	0	-100.00	25.00	-128,375
2014-12-01	2014-11-28	4	EBS	Emergent BioSolutions Inc. Common Stock	S - Sale	X	-14,355	0	-100.00	25.00	-358,875
2014-12-01	2014-11-26	4	EBS	Emergent BioSolutions Inc. Common Stock	S - Sale	X	-1,490	14,355	-9.40	25.00	-37,250	358,875
2014-11-26	2014-11-25	4	EBS	Emergent BioSolutions Inc. Common Stock	S - Sale	X	-2,126	5,135	-29.28	25.00	-53,150	128,375
2014-11-26	2014-11-24	4	EBS	Emergent BioSolutions Inc. Common Stock	S - Sale	X	-500	13,597	-3.55	25.00	-12,500	339,925
2014-11-26	2014-11-24	4	EBS	Emergent BioSolutions Inc. Common Stock	S - Sale	X	-6,388	7,261	-46.80	25.00	-159,700	181,525
2014-11-14	2014-11-12	4	EBS	Emergent BioSolutions Inc. Common Stock	S - Sale	X	-115	14,097	-0.81	25.00	-2,875	352,425
2014-11-14	2014-11-12	4	EBS	Emergent BioSolutions Inc. Common Stock	S - Sale	X	-2,196	13,649	-13.86	25.00	-54,900	341,225
2014-11-10	2014-08-26	4/A	EBS	Emergent BioSolutions Inc. Common Stock	S - Sale	X	-70,796	2,069,243	-3.31	25.00	-1,769,900	51,731,075
2014-11-10	2014-09-02	4/A	EBS	Emergent BioSolutions Inc. Common Stock	S - Sale	X	-1,633	14,212	-10.31	25.00	-40,825	355,300
2014-09-03	2014-09-02	4	EBS	Emergent BioSolutions Inc. Common Stock	F - Taxes	X	-1,633	14,212	-10.31	25.00	-40,825	355,300
2014-08-27	2014-08-26	4	EBS	Emergent BioSolutions Inc. Common Stock	F - Taxes	X	-70,769	2,069,243	-3.31	25.00	-1,769,225	51,731,075
2014-04-08	2014-03-14	4/A	EBS	Emergent BioSolutions Inc. Common Stock	F - Taxes		-3,659	2,140,039	-0.17	27.06	-99,013	57,909,455
2014-03-14	2014-03-12	4	EBS	Emergent BioSolutions Inc. Common Stock	F - Taxes		-3,659	2,141,275	-0.17	27.06	-99,013	57,942,902
2014-03-14	2014-03-12	4	EBS	Emergent BioSolutions Inc. Common Stock	F - Taxes		-1,463	2,144,934	-0.07	27.15	-39,720	58,234,958
2014-03-12	2014-03-11	4	EBS	Emergent BioSolutions Inc. Stock Option (Right to Buy)	A - Award		112,479	112,479
2014-03-12	2014-03-11	4	EBS	Emergent BioSolutions Inc. Common Stock	F - Taxes		-1,887	2,144,510	-0.09	28.09	-53,006	60,239,286
2014-03-12	2014-03-11	4	EBS	Emergent BioSolutions Inc. Common Stock	A - Award		56,240	2,146,397	2.69
2013-06-04	2013-05-31	4	EBS	Emergent BioSolutions Inc. Common Stock	J - Other		347,488	2,090,157	19.94
2013-04-19	2013-04-18	4	EBS	Emergent BioSolutions Inc. Common Stock	S - Sale		-62,851	1,742,669	-3.48	15.05	-945,606	26,218,804
2013-04-19	2013-04-17	4	EBS	Emergent BioSolutions Inc. Common Stock	S - Sale		-52,021	1,805,520	-2.80	15.02	-781,335	27,118,188
2013-04-19	2013-03-12	4/A	EBS	Emergent BioSolutions Inc. Common Stock	A - Award		20,902	1,861,191	1.14
2013-04-19	2013-03-12	4/A	EBS	Emergent BioSolutions Inc. Common Stock	F - Taxes		-1,463	1,840,289	-0.08	14.67	-21,462	26,997,040
2013-04-19	2013-03-08	4/A	EBS	Emergent BioSolutions Inc. Common Stock	F - Taxes		-3,818	1,841,752	-0.21	15.22	-58,110	28,031,465
2013-04-18	2013-03-14	4/A	EBS	Emergent BioSolutions Inc. Common Stock	F - Taxes		-3,659	1,857,532	-0.20	14.46	-52,909	26,859,913
2013-03-18	2013-03-08	4	EBS	Emergent BioSolutions Inc. Common Stock	F - Taxes		-4,294	1,856,053	-0.23	14.46	-62,091	26,838,526
2013-03-12	2013-03-12	4	EBS	Emergent BioSolutions Inc. Employee Stock Option (Right to buy)	A - Award		41,804	41,804
2013-03-12	2013-03-12	4	EBS	Emergent BioSolutions Inc. Common Stock	A - Award		20,902	1,860,347	1.14
2013-03-12	2013-03-12	4	EBS	Emergent BioSolutions Inc. Common Stock	F - Taxes		-1,717	1,839,445	-0.09	14.67	-25,188	26,984,658
2013-03-12	2013-03-08	4	EBS	Emergent BioSolutions Inc. Common Stock	F - Taxes		-4,408	1,841,162	-0.24	15.22	-67,090	28,022,486
2012-12-14	2012-12-14	4	EBS	Emergent BioSolutions Inc. Common Stock	G - Gift		149,712	149,712
2012-12-14	2012-12-14	4	EBS	Emergent BioSolutions Inc. Common Stock	G - Gift		13,333	13,333
2012-12-14	2012-12-14	4	EBS	Emergent BioSolutions Inc. Common Stock	G - Gift		13,333	13,333
2012-12-14	2012-12-14	4	EBS	Emergent BioSolutions Inc. Common Stock	G - Gift		-176,378	127,721	-58.00
2012-12-14	2012-12-14	4	EBS	Emergent BioSolutions Inc. Common Stock	G - Gift		224,628	224,628
2012-12-14	2012-12-12	4	EBS	Emergent BioSolutions Inc. Common Stock	G - Gift		304,098	304,098
2012-12-06	2012-12-04	4	EBS	Emergent BioSolutions Inc. Common Stock	S - Sale		-43,064	1,845,570	-2.28	15.08	-649,539	27,836,917
2012-12-03	2012-12-03	4	EBS	Emergent BioSolutions Inc. Common Stock	S - Sale		-22,875	1,888,634	-1.20	15.02	-343,576	28,366,716
2012-12-03	2012-11-30	4	EBS	Emergent BioSolutions Inc. Common Stock	S - Sale		-34,061	1,911,509	-1.75	15.21	-518,224	29,082,845
2012-09-20	2012-09-18	4	EBS	Emergent BioSolutions Inc. Common Stock	J - Other		150,000	1,945,570	8.35
2012-09-20	2012-09-18	4	EBS	Emergent BioSolutions Inc. Common Stock	J - Other		-150,000	4,344,250	-3.34
2012-06-06	2012-06-04	4	EBS	Emergent BioSolutions Inc. Common Stock	J - Other		-33,702	4,494,250	-0.74
2012-05-17	2012-05-16	4	EBS	Emergent BioSolutions Inc. Common Stock	J - Other		-191,950	4,527,952	-4.07
2012-05-17	2012-05-16	4	EBS	Emergent BioSolutions Inc. Common Stock	J - Other		281,190	1,795,570	18.57
2012-05-09	2012-05-08	4	EBS	Emergent BioSolutions Inc. Common Stock	J - Other		-779,951	4,719,902	-14.18
2012-05-09	2012-05-08	4	EBS	Emergent BioSolutions Inc. Common Stock	J - Other		-45,647	5,499,853	-0.82
2012-05-09	2012-05-08	4	EBS	Emergent BioSolutions Inc. Common Stock	J - Other		-45,647	5,499,853	-0.82
2012-05-09	2012-05-08	4	EBS	Emergent BioSolutions Inc. Common Stock	J - Other		-45,647	5,591,147	-0.81
2012-03-16	2012-03-14	4	EBS	Emergent BioSolutions Inc. Common Stock	F - Taxes		-3,538	1,514,380	-0.23	16.05	-56,785	24,305,799
2012-03-16	2012-03-13	4	EBS	Emergent BioSolutions Inc. Employee Stock Option (Right to buy)	A - Award		32,100	32,100
2012-03-16	2012-03-13	4	EBS	Emergent BioSolutions Inc. Common Stock	A - Award		16,050	1,517,918	1.07
2012-03-12	2012-03-08	4	EBS	Emergent BioSolutions Inc. Common Stock	F - Taxes		-3,730	1,501,868	-0.25	14.49	-54,048	21,762,067
2008-10-01	2008-09-29	4	EBS	Emergent BioSolutions Inc. Common Stock	S - Sale		-1,700	7,777,935	-0.02	15.17	-25,789	117,991,274
2008-10-01	2008-09-29	4	EBS	Emergent BioSolutions Inc. Common Stock	S - Sale		-2,200	7,779,635	-0.03	15.00	-33,000	116,694,525
2008-09-05	2008-08-28	4/A	EBS	Emergent BioSolutions Inc. Common Stock	S - Sale		-100	7,829,185	0.00	14.23	-1,423	111,409,303
2008-09-05	2008-08-28	4/A	EBS	Emergent BioSolutions Inc. Common Stock	S - Sale		-650	7,829,285	-0.01	14.22	-9,243	111,332,433
2008-09-05	2008-08-28	4/A	EBS	Emergent BioSolutions Inc. Common Stock	S - Sale		-200	7,829,935	0.00	14.21	-2,842	111,263,376
2008-09-05	2008-08-28	4/A	EBS	Emergent BioSolutions Inc. Common Stock	S - Sale		-500	7,830,135	-0.01	14.20	-7,100	111,187,917
2008-09-05	2008-08-28	4/A	EBS	Emergent BioSolutions Inc. Common Stock	S - Sale		-1,000	7,830,635	-0.01	14.19	-14,190	111,116,711
2008-09-05	2008-08-28	4/A	EBS	Emergent BioSolutions Inc. Common Stock	S - Sale		-400	7,831,635	-0.01	14.18	-5,672	111,052,584
2008-09-05	2008-08-28	4/A	EBS	Emergent BioSolutions Inc. Common Stock	S - Sale		-800	7,832,035	-0.01	14.17	-11,336	110,979,936
2008-09-05	2008-08-28	4/A	EBS	Emergent BioSolutions Inc. Common Stock	S - Sale		-50	7,832,835	0.00	14.16	-708	110,912,944
2008-09-05	2008-08-28	4/A	EBS	Emergent BioSolutions Inc. Common Stock	S - Sale		-100	7,832,885	0.00	14.15	-1,415	110,835,323
2008-09-05	2008-08-28	4/A	EBS	Emergent BioSolutions Inc. Common Stock	S - Sale		-200	7,832,985	0.00	14.14	-2,828	110,758,408
2008-09-05	2008-08-28	4/A	EBS	Emergent BioSolutions Inc. Common Stock	S - Sale		-700	7,833,185	-0.01	14.13	-9,891	110,682,904
2008-09-05	2008-08-28	4/A	EBS	Emergent BioSolutions Inc. Common Stock	S - Sale		-600	7,833,885	-0.01	14.12	-8,472	110,614,456
2008-09-05	2008-08-28	4/A	EBS	Emergent BioSolutions Inc. Common Stock	S - Sale		-300	7,834,485	0.00	14.11	-4,233	110,544,583
2008-09-05	2008-08-28	4/A	EBS	Emergent BioSolutions Inc. Common Stock	S - Sale		-600	7,834,785	-0.01	14.10	-8,460	110,470,468
2008-09-05	2008-08-28	4/A	EBS	Emergent BioSolutions Inc. Common Stock	S - Sale		-350	7,835,385	0.00	14.09	-4,932	110,400,575
2008-09-05	2008-08-28	4/A	EBS	Emergent BioSolutions Inc. Common Stock	S - Sale		-100	7,835,735	0.00	14.08	-1,408	110,366,327
2008-09-05	2008-08-28	4/A	EBS	Emergent BioSolutions Inc. Common Stock	S - Sale		-400	7,835,835	-0.01	14.08	-5,632	110,328,557
2008-09-05	2008-08-28	4/A	EBS	Emergent BioSolutions Inc. Common Stock	S - Sale		-1,700	7,836,235	-0.02	14.07	-23,919	110,255,826
2008-09-05	2008-08-28	4/A	EBS	Emergent BioSolutions Inc. Common Stock	S - Sale		-3,700	7,837,935	-0.05	14.06	-52,022	110,201,366
2008-09-05	2008-08-28	4/A	EBS	Emergent BioSolutions Inc. Common Stock	S - Sale		-200	7,841,635	0.00	14.05	-2,810	110,174,972
2008-09-05	2008-08-28	4/A	EBS	Emergent BioSolutions Inc. Common Stock	S - Sale		-100	7,841,835	0.00	14.04	-1,404	110,099,363
2008-09-05	2008-08-28	4/A	EBS	Emergent BioSolutions Inc. Common Stock	S - Sale		-800	7,841,935	-0.01	14.03	-11,224	110,022,348
2008-09-05	2008-08-28	4/A	EBS	Emergent BioSolutions Inc. Common Stock	S - Sale		-500	7,842,735	-0.01	14.02	-7,010	109,955,145
2008-09-05	2008-08-28	4/A	EBS	Emergent BioSolutions Inc. Common Stock	S - Sale		-300	7,843,235	0.00	14.01	-4,203	109,883,722
2008-09-05	2008-08-28	4/A	EBS	Emergent BioSolutions Inc. Common Stock	S - Sale		-200	7,843,535	0.00	14.00	-2,801	109,848,708
2008-09-05	2008-08-28	4/A	EBS	Emergent BioSolutions Inc. Common Stock	S - Sale		-8,000	7,843,735	-0.10	14.00	-112,000	109,812,290
2006-11-14		3	EBS	Emergent BioSolutions Inc. Common Stock				8,314,819
2006-11-14		3	EBS	Emergent BioSolutions Inc. Common Stock				4,065,043
2006-11-14		3	EBS	Emergent BioSolutions Inc. Common Stock				1,599,155
2006-11-14		3	EBS	Emergent BioSolutions Inc. Common Stock				719,275

공개 시장에서 또는 사적으로 비파생증권 또는 파생증권 매입

공개 시장에서 또는 사적으로 비파생증권 또는 파생증권 매각

자사로부터 유가증권(옵션 등)을 보조, 지급 또는 기타 취득

파생상품 전환

자사에게 유가증권을 매각 또는 양도

기업으로부터 인도 받은 유가증권의 일부를 사용한 행사 가격 또는 조세 채무의 지급

내부자에 의한 또는 내부자에게 증권 증여

지분스왑 및 유사 위험 회피거래

자사로부터 인도 받은 파생증권(옵션 등)의 행사 또는 전환

보고서 양식 4에 자진 신고된 거래

기타 (거래 내용을 설명하는 각주와 동반)